HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Günther Bernhardt Selected Research

Gentian Violet (Violet, Crystal)

1/2015Esters of Bendamustine Are by Far More Potent Cytotoxic Agents than the Parent Compound against Human Sarcoma and Carcinoma Cells.
2/2007Inhibitors of kinesin Eg5: antiproliferative activity of monastrol analogues against human glioblastoma cells.
5/2002Establishment and Characterization of New Murine Breast Cancer Cell Lines.
3/2002Establishment and characterization of new murine breast cancer cell lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Günther Bernhardt Research Topics

Disease

13Neoplasms (Cancer)
04/2021 - 05/2002
9Breast Neoplasms (Breast Cancer)
08/2015 - 03/2002
5Glioblastoma (Glioblastoma Multiforme)
03/2016 - 04/2003
4Carcinoma (Carcinomatosis)
10/2019 - 01/2012
2Sarcoma (Soft Tissue Sarcoma)
04/2021 - 01/2015
2Obesity
01/2017 - 12/2003
2Brain Neoplasms (Brain Tumor)
03/2016 - 09/2006
2Melanoma (Melanoma, Malignant)
01/2015 - 08/2008
2Bacterial Infections (Bacterial Infection)
09/2011 - 08/2006
2Urinary Bladder Neoplasms (Bladder Cancer)
05/2002 - 05/2002
1Renal Cell Carcinoma (Grawitz Tumor)
10/2019
1Multiple Myeloma
01/2015
1Lung Neoplasms (Lung Cancer)
01/2015
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2015
1Hematologic Neoplasms (Hematological Malignancy)
01/2015
1Colorectal Neoplasms (Colorectal Cancer)
01/2015
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2015
1Leukemia
08/2008
1Colonic Neoplasms (Colon Cancer)
08/2008
1Disease Progression
04/2007
1Hyperthermia
12/2004
1Brain Ischemia (Cerebral Ischemia)
07/2004

Drug/Important Bio-Agent (IBA)

7Proteins (Proteins, Gene)FDA Link
08/2018 - 09/2006
5LigandsIBA
03/2017 - 05/2002
5PlatinumIBA
03/2007 - 05/2002
4Gentian Violet (Violet, Crystal)FDA Link
01/2015 - 03/2002
4EnzymesIBA
09/2011 - 11/2002
4Cisplatin (Platino)FDA LinkGeneric
08/2008 - 03/2002
4Hormones (Hormone)IBA
06/2004 - 03/2002
3Neuropeptide YIBA
10/2019 - 01/2017
3Pharmaceutical PreparationsIBA
01/2017 - 11/2002
3Estrogen ReceptorsIBA
01/2012 - 06/2004
2Cytostatic AgentsIBA
04/2021 - 08/2015
2Bendamustine HydrochlorideFDA Link
04/2021 - 01/2015
2ATP-Binding Cassette Transporters (ABC Transporters)IBA
08/2015 - 06/2011
2Topotecan (Hycamtin)FDA LinkGeneric
08/2015 - 02/2009
2EstersIBA
01/2015 - 08/2008
2tariquidar (XR9576)IBA
06/2011 - 02/2009
2Member 1 Subfamily B ATP Binding Cassette TransporterIBA
02/2009 - 11/2002
2Paclitaxel (Taxol)FDA LinkGeneric
05/2008 - 11/2002
2valspodar (PSC 833)IBA
05/2008 - 11/2002
2DNA (Deoxyribonucleic Acid)IBA
03/2007 - 06/2004
2Estrogens (Estrogen)FDA Link
06/2004 - 06/2004
2DiaminesIBA
06/2004 - 06/2004
2ethylenediamine (ethylenediamine dihydroiodide)FDA Link
06/2004 - 06/2004
2ethyleneIBA
06/2004 - 06/2004
2Doxorubicin (Adriamycin)FDA LinkGeneric
05/2002 - 03/2002
2Vinblastine (Vinblastine Sulfate)FDA Link
05/2002 - 03/2002
2Methotrexate (Mexate)FDA LinkGeneric
05/2002 - 03/2002
2ovexIBA
05/2002 - 03/2002
2Fluorouracil (Carac)FDA LinkGeneric
05/2002 - 03/2002
2Carboplatin (JM8)FDA LinkGeneric
05/2002 - 03/2002
1Chlorambucil (Leukeran)FDA Link
04/2021
1bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA
01/2021
1Neurotensin Receptors (Neurotensin Receptor)IBA
06/2019
1argininamideIBA
03/2017
1BIBP 3226IBA
03/2017
1neuropeptide Y4 receptorIBA
01/2017
1ChemokinesIBA
03/2016
1Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA
03/2016
1paxillineIBA
03/2016
1Fura-2 (Fura 2)IBA
03/2016
1Messenger RNA (mRNA)IBA
03/2016
1Epithelial Cell Adhesion MoleculeIBA
08/2015
1Adenosine Triphosphate (ATP)IBA
08/2015
1Cytotoxins (Cytolysins)IBA
01/2015
1Alkylating AgentsIBA
01/2015
1CationsIBA
01/2015
1Estrogen Receptor Modulators (Antiestrogen)IBA
01/2012
1Mitoxantrone (Novantrone)FDA LinkGeneric
02/2009
1AlcoholsIBA
08/2008
1MentholFDA Link
08/2008
1Niacin (Nicotinic Acid)FDA LinkGeneric
08/2008
1isolongifololIBA
08/2008
1Terpenes (Terpenoids)IBA
08/2008
1Sex Hormone-Binding GlobulinIBA
03/2007
1SteroidsIBA
03/2007
1vasastrol VS-83IBA
02/2007
1enastronIBA
02/2007
1monastrolIBA
02/2007
1KinesinsIBA
02/2007
1dimethylenastronIBA
02/2007
1Imatinib Mesylate (Gleevec)FDA Link
09/2006
1Tyrosine Kinase InhibitorsIBA
09/2006
1Platelet-Derived Growth FactorIBA
09/2006
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
09/2006
1Becaplermin (PDGF-BB)FDA Link
09/2006
1Hyaluronic Acid (Hyaluronan)IBA
08/2006
1Anti-Bacterial Agents (Antibiotics)IBA
08/2006
1Antineoplastic Agents (Antineoplastics)IBA
12/2004
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2004
1Matrix Metalloproteinases (MMPs)IBA
07/2004
1Matrix Metalloproteinase InhibitorsIBA
07/2004
1EstroneFDA Link
06/2004
1hydroxide ionIBA
06/2004
1Blood Proteins (Serum Proteins)IBA
06/2004
1Neuropeptide Y Receptors (Neuropeptide Y Receptor)IBA
12/2003
1QuinazolinesIBA
12/2003

Therapy/Procedure

6Therapeutics
06/2019 - 03/2002
1Radiotherapy
03/2016